BBSRC Portfolio Analyser
Award details
Natural immunity to haematopoietic cells - An opportunity for cellular therapy of cancer
Reference
BBS/E/B/0000H160
Principal Investigator / Supervisor
Professor Francesco Colucci
Co-Investigators /
Co-Supervisors
Institution
Babraham Institute
Department
Babraham Institute Department
Funding type
Research
Value (£)
121,739
Status
Completed
Type
Institute Project
Start date
01/07/2005
End date
30/06/2008
Duration
36 months
Abstract
Natural Killer (NK) lymphocytes are white blood cells that spontaneously attack virally infected and malignant cells. They can also naturally react against transplanted blood cells. These are important qualities that can be exploited in the clinics to improve treatment of leukaemia and bone marrow transplantation. However we do not fully understand precisely how NK cells are triggered in these situations. Our research aims at understanding the molecular switch that control NK cells activation during bone marrow transplantation and leukaemia. A better characterisation of these pathways will provide a rational basis to improve cures for cancer.
Summary
unavailable
Committee
Closed Committee - Biochemistry & Cell Biology (BCB)
Research Topics
Immunology
Research Priority
X – Research Priority information not available
Research Initiative
X - not in an Initiative
Funding Scheme
X – not Funded via a specific Funding Scheme
I accept the
terms and conditions of use
(opens in new window)
export PDF file
back to list
new search